These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9425708)

  • 1. Why PSA testing does have value.
    Kirby M
    Practitioner; 1997 Jul; 241(1576):363. PubMed ID: 9425708
    [No Abstract]   [Full Text] [Related]  

  • 2. PSA screening: the bottom line.
    Elhilali MM
    CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
    [No Abstract]   [Full Text] [Related]  

  • 3. How valuable is prostate-specific antigen screening?
    Handler S
    Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
    [No Abstract]   [Full Text] [Related]  

  • 4. Is an improved PSA screening test in sight?
    Savage L
    J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract]   [Full Text] [Related]  

  • 5. Does screening with prostate/specific antigen improve outcomes?
    Ohrt D
    Minn Med; 1996 Apr; 79(4):50-1. PubMed ID: 8637494
    [No Abstract]   [Full Text] [Related]  

  • 6. [The PSA test does not hold for screening. Good--but not good enough].
    Holmström B; Johansson M; Bratt O; Stattin P
    Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
    [No Abstract]   [Full Text] [Related]  

  • 7. The cautionary tale of PSA testing.
    Hoffman RM; Zeliadt SB
    Arch Intern Med; 2010 Jul; 170(14):1262-3. PubMed ID: 20660847
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC).
    Roobol MJ; Zappa M; Määttänen L; Ciatto S
    Prostate; 2007 Mar; 67(4):439-46. PubMed ID: 17192912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer.
    D'Amico AV
    J Clin Oncol; 2008 Feb; 26(6):823-4. PubMed ID: 18281649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Legal (liability) aspects of PSA determination].
    Mielke K
    Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
    [No Abstract]   [Full Text] [Related]  

  • 12. [Screening for prostate cancer: role of PSA in 2006].
    Roumeguère T; Peltier A
    Rev Med Brux; 2006 Sep; 27(4):S225-31. PubMed ID: 17091883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.
    Perrin P
    Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Rosser CJ; Parker A
    J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.
    Hernández J; Thompson IM
    Cancer; 2004 Sep; 101(5):894-904. PubMed ID: 15329895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
    Raaijmakers R; Wildhagen MF; Ito K; Pàez A; de Vries SH; Roobol MJ; Schröder FH
    Urology; 2004 Feb; 63(2):316-20. PubMed ID: 14972481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer detection: beware of the low PSA.
    Haas GP
    Can J Urol; 2007 Jun; 14(3):3534. PubMed ID: 17594742
    [No Abstract]   [Full Text] [Related]  

  • 19. Early detection of prostate cancer: is PSA a reliable option?
    Okihara K; Babaian RJ
    Tex Med; 2001 Feb; 97(2):59-62. PubMed ID: 11233061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: is the PSA test the answer?
    Berlin B
    N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.